AdvaMed Submits Comments on the CY 2023 PFS Proposed Rule
AdvaMed submitted comments to CMS on the Calendar Year 2023 Physician Fee Schedule (PFS) proposed rule.
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
AdvaMed submitted comments to CMS on the Calendar Year 2023 Physician Fee Schedule (PFS) proposed rule.
AdvaMed submitted a letter to CMS’s RFI on Medicare regarding ways to strengthen the Medicare Advantage program to align with the Vision for Medicare and CMS’ Strategic Pillars.
AdvaMed submitted comments to CMS the CY 2023 End Stage Renal Disease (ESRD) Prospective Payment System.
AdvaMed submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
AdvaMed submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
AdvaMed submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…
AdvaMed submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”
Based on insights from a related workshop series, this document outlines potential considerations and possible approaches to help research sponsors improve inclusion of under-represented groups in clinical research.